Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Loss of KDM6A Confers Drug Resistance in Acute Myeloid Leukemia

Sophie M. Stief, M.Sc., Anna-Li Hanneforth, Raphael Mattes, Sabrina Weser, M.Sc., Binje Vick, PhD, Michael D. Bartoschek, M.Sc., Helena Domínguez Moreno, M.Sc., Wen-Hsin Liu, PhD, Bianka Ksienzyk, Maja Rothenberg-Thurley, PhD, Hilmar Quentmeier, PhD, Wolfgang Hiddemann, Klaus H. Metzeler, MD, Gunnar Schotta, PhD, Sebastian Bultmann, PhD, Irmela Jeremias, MD PhD, Heinrich Leonhardt, PhD, Karsten Spiekermann, MD

Blood (2018) 132 (Supplement 1): 3935.

https://doi.org/10.1182/blood-2018-99-114959

Published: 2018

Journal Articles

SLAMF7 in Primary Effusion Lymphoma, Target for Individualized Therapy?

Hilmar Quentmeier, PhD, Claudia Pommerenke, PhD, Wilhelm G Dirks, PhD, Vivien Hauer, Max Koeppel, PhD, Stefan Nagel, PhD, Michaela Scherr, PhD, Margarete Zaborski, Hans G. Drexler, MD PhD

Blood (2018) 132 (Supplement 1): 5300.

https://doi.org/10.1182/blood-2018-99-110054

Published: 2018

Journal Articles

Epigenetic Modifier Mutations in the LL-100 Panel

Hilmar Quentmeier, PhD, Claudia Pommerenke, PhD, Hans G. Drexler, MD PhD

Blood (2018) 132 (Supplement 1): 5271.

https://doi.org/10.1182/blood-2018-99-110060

Published: 2018

Journal Articles

A New Entity of Acute Myeloid Leukemia Driven By Epigenetic and Somatic Dis-Regulation of Uncx , a Novel Homeobox Transcription Factor Gene

Blood (2015) 126 (23): 1356.

https://doi.org/10.1182/blood.V126.23.1356.1356

Published: 2015

Journal Articles

FOXR1 Activation in B-Cell Lymphoma

Hilmar Quentmeier, PhD, Claudia Pommerenke, PhD, Stefan Nagel, PhD, Vivien Hauer, Margarete Zaborski, Rose Marie Amini, PhD, Mattias Berglund, PhD, Robert Geffers, PhD, Hans G Drexler, Prof. MD

Blood (2015) 126 (23): 2422.

https://doi.org/10.1182/blood.V126.23.2422.2422

Published: 2015

Journal Articles

BCL6 Overexpression – Regulated By AhR/ARNT and Wild-Type MEF2B – Drives Expression of Germinal Center Markers MYBL1 and LMO2

Hilmar Quentmeier, PhD, Jie Ding, PhD, Willy Dirks, PhD, Stefan Ehrentraut, PhD, Robert Geffers, PhD, Rod AF MacLeod, PhD, Stefan Nagel, PhD, Michaela Scherr, Lea AI Vaas, PhD, Hans G Drexler, Prof. MD

Blood (2014) 124 (21): 865.

https://doi.org/10.1182/blood.V124.21.865.865

Published: 2014

Journal Articles

Inhibition Of PI3K/mTOR Overcomes Nilotinib Resistance In BCR-ABL1 Positive Leukemia Cells

Jie Ding, PhD, Julia Romani, Margarete Zaborski, Roderick AF MacLeod, PhD, Stefan Nagel, PhD, Hans G. Drexler, MD, PhD, Hilmar Quentmeier, PhD

Blood (2013) 122 (21): 4906.

https://doi.org/10.1182/blood.V122.21.4906.4906

Published: 2013

Journal Articles

T(8;9)(p22;p24)/PCM1-JAK2 Activates SOCS2 and SOCS3 Via STAT5

Stefan Ehrentraut, Stefan Nagel, PhD, Michaela Scherr, Bjoern Schneider, Hilmar Quentmeier, PhD, Robert Geffers, PhD, Monika Prochorec-Sobieszek, Rhett P Ketterling, MD, Ryan A Knudson, Andrew L. Feldman, MD, Marshall Kadin, Hans G. Drexler, MD, PhD, Roderick AF MacLeod

Blood (2012) 120 (21): 1567.

https://doi.org/10.1182/blood.V120.21.1567.1567

Published: 2012

Journal Articles

Induction of Apoptosis In Imatinib-Resistant BCR-ABL1 -Positive Leukemia Cell Lines by Bortezomib

Hilmar Quentmeier, PhD, Sonja Eberth, PhD, Julia Romani, Margarete Zaborski, Hans G. Drexler, MD, PhD

Blood (2010) 116 (21): 4469.

https://doi.org/10.1182/blood.V116.21.4469.4469

Published: 2010

Journal Articles

CRLF2 and JAK2 Mutations: Occurrence and Function In Pre-B ALL Cell Lines

Hilmar Quentmeier, PhD, Sonja Eberth, PhD, Roderick AF MacLeod, PhD, Stefan Nagel, PhD, Julia Romani, Margarete Zaborski, Hans G. Drexler, MD, PhD

Blood (2010) 116 (21): 5109.

https://doi.org/10.1182/blood.V116.21.5109.5109

Published: 2010

Journal Articles

Hypomethylation of Tumor Suppressor Genes in Acute Myeloid Leukemia: Characteristic of Cell Lines with MLL Abnormalities?.

Hilmar Quentmeier, Sonja Röhrs, Wilhelm G Dirks, Claus Meyer, Rolf Marschalek, Michaela Scherr, Robert K. Slany, PhD, Andrew Wallace, Hans G. Drexler

Blood (2009) 114 (22): 365.

https://doi.org/10.1182/blood.V114.22.365.365

Published: 2009

Journal Articles

Spliceosomal Targeting in Acute Myeloid Leukemia Cells with ETV6-NTRK3 Fusion.

Suning Chen, Bjoern Schneider, Stefan Nagel, Robert Geffers, Maren Kaufmann, Hilmar Quentmeier, Hans G. Drexler, Roderick A.F. MacLeod

Blood (2009) 114 (22): 5042.

https://doi.org/10.1182/blood.V114.22.5042.5042

Published: 2009

Journal Articles

Hypermethylation of CD44 Is Characteristic of Specific Lymphoma Subtypes.

Sonja Röhrs, Julia Romani, Margarete Zaborski, Andreas Rosenwald, Hans G. Drexler, Hilmar Quentmeier

Blood (2009) 114 (22): 3469.

https://doi.org/10.1182/blood.V114.22.3469.3469

Published: 2009

Journal Articles

Amplification at 7q22 Targets CDK6 in T-Cell Lymphoma.

Stefan Nagel, Ellen Leich, Hilmar Quentmeier, Corinna Meyer, Andreas Zettl, Hans G. Drexler, Andreas Rosenwald, Roderick A.F. MacLeod

Blood (2007) 110 (11): 3563.

https://doi.org/10.1182/blood.V110.11.3563.3563

Published: 2007

Journal Articles

Methylation Status of Tumor Suppressor Genes BEX2, IGSF4, RARB and TIMP3 Is Indicative for AML with Translocations of the MLL Gene.

Hilmar Quentmeier, PhD, Willy G. Dirks, PhD, Stefan Nagel, PhD, Sonja Röhrs, PhD, Björn Schneider, PhD, Hans G. Drexler, PhD

Blood (2007) 110 (11): 2115.

https://doi.org/10.1182/blood.V110.11.2115.2115

Published: 2007

Journal Articles

Comprehensive analysis of homeobox genes in Hodgkin lymphoma cell lines identifies dysregulated expression of HOXB9 mediated via ERK5 signaling and BMI1

Stefan Nagel, Christof Burek, Letizia Venturini, Michaela Scherr, Hilmar Quentmeier, Corinna Meyer, Andreas Rosenwald, Hans G. Drexler, Roderick A. F. MacLeod

Blood (2006) 109 (7): 3015–3023.

https://doi.org/10.1182/blood-2006-08-044347

Published: 2006

Includes: Supplemental data

Journal Articles

Analysis of MLL Amplification and 5q Deletions in AML/MDS Cell Lines Identifies Novel Targets.

Bjoern Schneider, Stefan Nagel, PhD, Maren Kaufmann, Hilmar Quentmeier, PhD, Yoshinobu Matsuo, PhD, Hans G. Drexler, MD, Roderick A.F. MacLeod, PhD

Blood (2006) 108 (11): 1424.

https://doi.org/10.1182/blood.V108.11.1424.1424

Published: 2006

Journal Articles

Comprehensive Analysis of Homeobox Genes in Hodgkin Lymphoma Cell Lines Identified Dysregulated Expression of HOXB9 Mediated by Constitutive Active ERK5 Signalling Pathway and BMI1.

Stefan Nagel, PhD, Cristof Burek, PhD, Letizia Venturini, PhD, Michaela Scherr, PhD, Hilmar Quentmeier, PhD, Corinna Meier, Andreas Rosenwald, MD, Hans G. Drexler, MD, Roderick A.F. MacLeod, PhD

Blood (2006) 108 (11): 471.

https://doi.org/10.1182/blood.V108.11.471.471

Published: 2006

Journal Articles

Oncogenic CBL Mutants Have Transforming Potential in Cells Expressing the FLT3 Tyrosine Kinase.

Carola Reindl, Sridhar Vempati, Hilmar Quentmeier, Gudrun Mellert, Wolfgang Hiddemann, Karsten Spiekermann

Blood (2006) 108 (11): 1446.

https://doi.org/10.1182/blood.V108.11.1446.1446

Published: 2006

Journal Articles

JAK2 V617F Tyrosine Kinase Mutation in Leukemia Cell Lines.

Hilmar Quentmeier, PhD, Roderick A.F. MacLeod, PhD, Julia Reinhardt, Margarete Zaborski, Hans G. Drexler, PhD

Blood (2005) 106 (11): 4505.

https://doi.org/10.1182/blood.V106.11.4505.4505

Published: 2005

NARROW

Loss of KDM6A Confers Drug Resistance in Acute Myeloid Leukemia

SLAMF7 in Primary Effusion Lymphoma, Target for Individualized Therapy?

Epigenetic Modifier Mutations in the LL-100 Panel

A New Entity of Acute Myeloid Leukemia Driven By Epigenetic and Somatic Dis-Regulation of Uncx , a Novel Homeobox Transcription Factor Gene

FOXR1 Activation in B-Cell Lymphoma

BCL6 Overexpression – Regulated By AhR/ARNT and Wild-Type MEF2B – Drives Expression of Germinal Center Markers MYBL1 and LMO2

Inhibition Of PI3K/mTOR Overcomes Nilotinib Resistance In BCR-ABL1 Positive Leukemia Cells

T(8;9)(p22;p24)/PCM1-JAK2 Activates SOCS2 and SOCS3 Via STAT5

Induction of Apoptosis In Imatinib-Resistant BCR-ABL1 -Positive Leukemia Cell Lines by Bortezomib

CRLF2 and JAK2 Mutations: Occurrence and Function In Pre-B ALL Cell Lines

Hypomethylation of Tumor Suppressor Genes in Acute Myeloid Leukemia: Characteristic of Cell Lines with MLL Abnormalities?.

Spliceosomal Targeting in Acute Myeloid Leukemia Cells with ETV6-NTRK3 Fusion.

Hypermethylation of CD44 Is Characteristic of Specific Lymphoma Subtypes.

Amplification at 7q22 Targets CDK6 in T-Cell Lymphoma.

Methylation Status of Tumor Suppressor Genes BEX2, IGSF4, RARB and TIMP3 Is Indicative for AML with Translocations of the MLL Gene.

Comprehensive analysis of homeobox genes in Hodgkin lymphoma cell lines identifies dysregulated expression of HOXB9 mediated via ERK5 signaling and BMI1

Analysis of MLL Amplification and 5q Deletions in AML/MDS Cell Lines Identifies Novel Targets.

Comprehensive Analysis of Homeobox Genes in Hodgkin Lymphoma Cell Lines Identified Dysregulated Expression of HOXB9 Mediated by Constitutive Active ERK5 Signalling Pathway and BMI1.

Oncogenic CBL Mutants Have Transforming Potential in Cells Expressing the FLT3 Tyrosine Kinase.

JAK2 V617F Tyrosine Kinase Mutation in Leukemia Cell Lines.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only